Dr. Lisa Garcia -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Lisa Garcia, a Oncology physician based in City, CO. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Lisa Garcia has received $123,182.45 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Lisa Garcia has received a total of $123,182.45 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $123,182.45 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Lisa Garcia's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Research Funding$123,182.45Clinical trial funding, research grants, and study-related payments

The largest payment category for Dr. Lisa Garcia is Research Funding, accounting for 100% ($123,182.45) of total pharmaceutical payments received. This suggests active involvement in clinical trials and pharmaceutical research programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Lisa Garcia. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
AbbVie Inc$123,182.451

Dr. Lisa Garcia has a financial relationship with AbbVie Inc, receiving $123,182.45 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Lisa Garcia's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Lisa Garcia has received $123.2K across 1 pharmaceutical payments as a Oncology physician in City, CO. Top paying companies include AbbVie Inc ($123.2K). Dr. Garcia received a single, substantial payment of $123,182 in 2024, exclusively from AbbVie Inc. This payment was categorized as 'research', indicating a potential focus on clinical trials or studies. The entire payment amount comes from one company, highlighting a high concentration of pharmaceutical funding from a single source.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Lisa Garcia is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

When discussing treatment options with Dr. Garcia, it's advisable to inquire about any potential research affiliations or sponsored treatments that might influence recommendations. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Lisa Garcia Compares to Other Oncology Physicians

Oncologists often engage in research collaborations with pharmaceutical companies, and Dr. Garcia's profile aligns with this, though the singular large payment warrants further context.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Lisa Garcia in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
AbbVie Inc$123,182.45researchN/A2024-05-16Not Assessed

Frequently Asked Questions About Dr. Lisa Garcia's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Lisa Garcia received?

Lisa Garcia has received a total of $123.2K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Lisa Garcia taking too much pharma money?

Lisa Garcia has received $123.2K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Oncology), the types of payments, and how they compare to peers. The largest payment category is research ($123.2K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Lisa Garcia?

The top pharmaceutical companies paying Lisa Garcia are: AbbVie Inc ($123.2K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Lisa Garcia receive?

Lisa Garcia's payments by type: research: $123.2K. Research payments indicate involvement in clinical studies.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Lisa Garcia's payments compare to other Oncology doctors?

To compare, look at the total amount ($123.2K), number of payments (1), and the types of payments received. Oncology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Lisa Garcia's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1966672520). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Lisa Garcia's pharma payment profile?

The doctor's payment profile is dominated by a single transaction, making it difficult to assess broader payment patterns. Lisa Garcia has received $123.2K in total pharma payments.

How does Lisa Garcia compare to peers in Oncology?

Oncologists often engage in research collaborations with pharmaceutical companies, and Dr. Garcia's profile aligns with this, though the singular large payment warrants further context.

Are Lisa Garcia's pharma relationships typical for Oncology?

The high average payment ($123,182) is solely due to this one large research payment.

What should patients of Lisa Garcia know about these payments?

When discussing treatment options with Dr. Garcia, it's advisable to inquire about any potential research affiliations or sponsored treatments that might influence recommendations.

What patterns are visible in Lisa Garcia's payment history?

The 100% top company concentration suggests a strong, potentially exclusive, relationship with AbbVie Inc. for this period.

Understanding This Doctor Payment Report

This transparency report for Dr. Lisa Garcia is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Lisa Garcia's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Lisa Garcia and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.